Foghorn Therapeutics (FHTX) EBITDA Margin (2020 - 2026)
Foghorn Therapeutics (FHTX) reported EBITDA Margin of -53.54% for Q2 2026, up 213.72 percentage points from -267.26% a year earlier and up 599.51 percentage points from the prior quarter.
Powered by 
Analysis
Foghorn Therapeutics (FHTX) EBITDA Margin (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Foghorn Therapeutics' EBITDA Margin came in at -192.21%, up 174.81 percentage points year-over-year; for FY2025, it came in at -268.71%, up 171.79 percentage points from FY2024.
- EBITDA Margin has a five-year change of +15360.12 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -440.51% in FY2024 (-134.82 pp), -305.68% in FY2023 (+286.25 pp), -591.93% in FY2022 (+6800.57 pp) and -7392.49% in FY2021 (+8236.34 pp).
- The Q2 2026 figure ranks as the highest quarterly EBITDA Margin in data going back to Q3 2020.
- Year over year, EBITDA Margin gained in five of the last eight quarters, with an average year-over-year change of +32.88 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q3 2022 (a gain of 61687.59 percentage points); the low point was Q3 2021 (a drop of 51938.55 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -653.05% (Q1 2026), -249.55% (Q4 2025) and -215.88% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Foghorn Therapeutics | 206.67 Mn | -119.28 Mn | - | -53.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -53.54% |
| Mar 31, 2026 | -653.05% |
| Dec 31, 2025 | -249.55% |
| Sep 30, 2025 | -215.88% |
| Jun 30, 2025 | -267.26% |
| Mar 31, 2025 | -371.07% |
| Dec 31, 2024 | -815.30% |
| Sep 30, 2024 | -296.52% |
| Jun 30, 2024 | -375.03% |
| Mar 31, 2024 | -541.76% |
| Dec 31, 2023 | -425.69% |
| Sep 30, 2023 | -92.58% |
| Jun 30, 2023 | -558.14% |
| Mar 31, 2023 | -610.60% |
| Dec 31, 2022 | -742.47% |
| Sep 30, 2022 | -412.41% |
| Jun 30, 2022 | -632.25% |
| Mar 31, 2022 | -688.60% |
| Dec 31, 2021 | -3,824.96% |
| Sep 30, 2021 | -62,100.00% |
API Access
Foghorn Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=FHTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "FHTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=FHTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();